AstraZeneca received subpoenas from state regulators in California and Alaska last month seeking information about its marketing of a Seroquel, an antipsychotic medication.
In a document posted on its Web site, AstraZeneca said it received a subpoena from the California Attorney General's Office seeking information about the marketing and sale of Seroquel in the state. The subpoena also sought information about the drug's status on the "state's formulary," AstraZeneca said, which could be a reference to state programs covering prescription drugs.
